|
Market Cap (3-Jul) $176,237,888 (1,192nd) |
Close (28-Sep) $0.205 |
Volume (28-Sep) 0 |
Shortsold (21-Sep) 297,501 (0.03%) (573rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.009 |
RAP released this announcement to the ASX on 26 October 2020, 13:44. The announcement is not marked as price sensitive, and is 49 page(s) in length and 1.69MB in size.
You can view all announcements from RAP and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAP was 0.172% short sold according to ASIC data. It was ranked the 379th most shorted stock on the ASX. It remains ranked 573rd as of the latest reported data (21 September 2022).
| Other Recent Announcements from RAP | |
|---|---|
| Removal from Official List | 27 September 2022, 11:58 |
| Scheme of Arrangement has been Implemented | 26 September 2022, 16:28 |
| Ceasing to be a substantial holder | 20 September 2022, 8:09 |
| Notice of Annual General Meeting/Proxy Form | 26 October 2020, 13:44 |
| AstraZeneca to use new ResApp software in study - Revised | 22 October 2020, 10:45 |
| Pause in Trading | 22 October 2020, 9:58 |
| AstraZeneca to use new ResApp software in clinical study | 22 October 2020, 9:31 |
You must be logged in to post a reply.
ResApp Health 